SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001013762-24-002642
Filing Date
2024-07-30
Accepted
2024-07-30 16:00:20
Documents
14
Period of Report
2024-07-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0210183-8k_inmune.htm   iXBRL 8-K 23444
2 PRESS RELEASE DATED JULY 25, 2024 ea021018301ex99-1_inmune.htm EX-99.1 10385
  Complete submission text file 0001013762-24-002642.txt   212467

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inmb-20240725.xsd EX-101.SCH 3018
4 XBRL LABEL FILE inmb-20240725_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE inmb-20240725_pre.xml EX-101.PRE 22361
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0210183-8k_inmune_htm.xml XML 3793
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 241157229
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)